PHILADELPHIA (AP) _ Amicus Therapeutics Inc. (FOLD) on Monday reported a loss of $85.3 million in its first quarter.On a per-share basis, the Philadelphia-based company said it had a loss of 30 cents.The results fell short of Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 24 cents per share.The pharmaceutical company posted revenue of $78.7 million in the period, surpassing Street forecasts. Three analysts surveyed by Zacks expected $77 million._____This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on FOLD at https://www.zacks.com/ap/FOLD